BioSpace News Archive

Business

Pia Baumann takes up her position as Chief Medical Officer

Medivir AB announced that the company’s new Chief Medical Officer Pia Baumann took up her position.

February 21, 2023

·

2 min read

Policy

NMPA accepted the registration applications for Uro-G and Uro-3500

Asieris Pharmaceuticals announced that the registration applications for the single-use, handheld electronic cystoscope cannula Uro-G and the electronic endoscope image processor Uro-3500 it represents have been accepted by the National Medical Products Administration.

February 21, 2023

·

4 min read

Business

Invitation to Presentation of BioInvent’s Year-End Report 2022

BioInvent International AB invites investors and analysts to a presentation of the Year-end report 2022 at 2:00 pm CET on February 22.

February 21, 2023

·

2 min read

Drug Development

Amydis Announces Enrollment of Cerebral Amyloid Angiopathy Participants in Phase 1/2a Retinal Tracer Trial

Amydis Inc. announced initiation of enrollment of patients with cerebral amyloid angiopathy, an age-associated disease in which a protein called amyloid beta builds up on the walls of the arteries in the brain increasing the risk for stroke and dementia.

February 21, 2023

·

2 min read

AbCheck Announces Collaboration to Apply Microfluidics Technology to the Discovery of Antibodies Against Challenging Therapeutic Neurology Target

AbCheck s.r.o. announced that it has entered into a collaboration with a biotech company developing antibodies targeting peripheral neural response, funded by a top-tier European Venture Capital firm.

February 21, 2023

·

2 min read

Business

LEX Diagnostics Appoints Scott O’Brien as LEX Board member

LEX Diagnostics announces the appointment of Scott O’Brien to the LEX Board.

February 21, 2023

·

2 min read

Business

Nordic Nanovector ASA: Invitation to Second Half and Full Year 2022 Results Presentation and Webcast

Nordic Nanovector ASA announces that it will report its results for the second half and full year 2022 on Tuesday, 28 February 2023.

February 21, 2023

·

1 min read

Business

Theravance Biopharma to Report Fourth Quarter and Full Year 2022 Financial Results on February 27, 2023

Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its fourth quarter and full year 2022 financial results and provide a business update after market close on Monday, February 27, 2023.

February 21, 2023

·

1 min read

Genetown

Highly Anticipated Omnipod® 5 Real-World Evidence to be Presented at the 16th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

Insulet Corporation announced the presentation of new real-world evidence related to the Omnipod® 5 Automated Insulin Delivery System at the 16th International Conference on Advanced Technologies & Treatments for Diabetes taking place February 22 – 25, 2023 in Berlin, Germany, and online.

February 21, 2023

·

6 min read

Aplantex Secures the Ideal Industrial Facility to Implement Its Strategic Plan

Mr. Patrick Charest, B. Sc., P. Eng., CEO of Aplantex, is pleased to announce that the company has secured its first industrial facility to implement its strategic plan.

February 21, 2023

·

2 min read